GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (OTCPK:ESALF) » Definitions » Purchase Of Investment

ESALF (Eisai Co) Purchase Of Investment : $-31 Mil (TTM As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Eisai Co Purchase Of Investment?

Eisai Co's purchase of investment for the three months ended in Dec. 2024 was $-2 Mil. It means Eisai Co spent $2 Mil on purchasing investments. Eisai Co's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2024 was $-31 Mil.

Compared with last quarter ($-14 Mil in Sep. 2024 ), Eisai Co spent less money on purchasing investments in Dec. 2024 ($-2 Mil).


Eisai Co Purchase Of Investment Historical Data

The historical data trend for Eisai Co's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Purchase Of Investment Chart

Eisai Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.95 -24.43 -26.41 -27.69 -43.35

Eisai Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.32 -7.90 -7.24 -13.94 -2.11

Eisai Co Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eisai Co Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Eisai Co's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Eisai Co Business Description

Traded in Other Exchanges
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co Headlines

From GuruFocus

Eisai Co Ltd Clarity AD Study Briefing Transcript

By GuruFocus Research 02-13-2024

Full Year 2021 Eisai Co Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Eisai Co Ltd Information Meeting Transcript

By GuruFocus Research 02-13-2024

Q3 2023 Eisai Co Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Eisai Co Ltd Information Meeting Transcript

By GuruFocus Research 03-14-2024

Q1 2023 Eisai Co Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2024 Eisai Co Ltd Earnings Presentation Transcript

By GuruFocus Research 02-13-2024